21 October 2022
A licence agreement between the Medicines Patent Pool (MPP) and Novartis will allow manufacturers to produce and supply generic versions of nilotinib.
Tag: leukemia
12 September 2019
The effort uses the same technology as last year’s highly controversial experiment by scientist He Jiankui.